Category: Tort Updates

Digital Evidence Uber and Lyft PI Firms Can’t Afford to Ignore
March 31, 2026 by Mohr Marketing In rideshare assault litigation, the single biggest shift in the last decade is the move from “he said, she said” to “the data said.” Plaintiff mass tort and personal injury firms that win against Uber and Lyft are the ones that treat digital evidence as a central pillar of their case strategy, not an afterthought.… Continue reading Digital Evidence Uber and Lyft PI Firms Can’t Afford to Ignore
Lyft Sex Assault Cases Rideshare Lawsuit Uber Sex Assault Cases
Trauma‑Informed Intake for Uber and Lyft Assault Cases
March 31, 2026 by Mohr Marketing Trauma‑Informed Intake for Uber and Lyft Sexual Assault Clients: Why Survivors First Strengthens Your Cases Rideshare assault litigation is never just about documents and data. At its core, it is about people—survivors whose lives have been altered during what should have been an ordinary ride. For personal injury and mass tort firms entering this space,… Continue reading Trauma‑Informed Intake for Uber and Lyft Assault Cases
Lyft Sex Assault Cases Rideshare Lawsuit Uber Sex Assault Cases
Mohr & RealSource Launch Rideshare Sexual Assault Partnership
March 30, 2026 by Mohr Marketing Mohr Marketing and RealSource Launch Evidence‑Ready Litigation Partnership for Uber and Lyft Sexual Assault Cases Strategic alliance delivers forensic‑backed case files and survivor‑centric intake to law firms handling rideshare assault litigation ALLENTOWN, PA – March 25, 2026 – Mohr Marketing and RealSource today announced a comprehensive litigation support partnership designed to provide personal injury and… Continue reading Mohr & RealSource Launch Rideshare Sexual Assault Partnership
Lyft Sex Assault Cases Rideshare Lawsuit Uber Sex Assault Cases
Evidence‑Ready Uber and Lyft Assault Case Intake
March 30, 2026 by Mohr Marketing From Cold Leads to Evidence‑Ready Uber and Lyft Assault Cases: A Better Intake Model for PI and Mass Tort Firms Most personal injury and mass tort firms know the frustration of cold leads. A name, a phone number, and a vague allegation might look like opportunity on paper, but in practice it often means weeks… Continue reading Evidence‑Ready Uber and Lyft Assault Case Intake
Lyft Sex Assault Cases Rideshare Lawsuit Uber Sex Assault Cases
The Blueprint for Rideshare Justice
March 26, 2026 by Mohr Marketing The Silent Crisis in Rideshare Safety In the modern transportation landscape, a dark reality persists beneath the surface of convenience. Every eight minutes, a life-altering incident occurs in a rideshare vehicle. For years, industry giants like Uber and Lyft have maintained a facade of safety, but the truth is becoming undeniable: they lied on their… Continue reading The Blueprint for Rideshare Justice
Lyft Sex Assault Cases Rideshare Lawsuit Uber Sex Assault Cases
Digital Evidence in Uber and Lyft Assault Lawsuits
March 26, 2026 by Mohr Marketing The Digital Edge for Uber and Lyft Assault Lawsuits: How Data Helps Your Uber Sexual Assault Clients Win In rideshare assault litigation, the difference between a difficult case and a dominant one often comes down to what is hiding in the data. While a survivor’s testimony is the heart of the story, digital proof is… Continue reading Digital Evidence in Uber and Lyft Assault Lawsuits
Lyft Sex Assault Cases Rideshare Lawsuit Uber Sex Assault Cases
Building Your MDL 3140 Portfolio with Precision
March 16, 2026 by Mohr Marketing Safeguarding Your Firm’s Depo-Provera (MDL 3140) Inventory As the pharmaceutical liability landscape shifts toward MDL 3140 (In re: Depo-Provera Products Liability Litigation), many firms are facing a critical operational choice: build volume quickly or build volume correctly. While the potential plaintiff pool for Depo-Provera is massive—estimated at 74 million women worldwide—the clinical criteria required to… Continue reading Building Your MDL 3140 Portfolio with Precision
Compliance Shield Depo-Provera Liability Litigation
Build a High-Value Depo-Provera Docket with Verified, Audit-Ready Retainers
March 15, 2026 by Mohr Marketing Don’t settle for “intake noise.” Leverage our Compliance Shield protocol to acquire signed plaintiffs with 12+ months of usage and imaging-confirmed Intracranial Meningiomas. The Opportunity: Why Pfizer (MDL 3140) Now? Massive Solvency: Unlike other defendants, Pfizer holds immense liquidity, ensuring the “muscle” to absorb global settlements. Scientific Catalyst: A March 2024 BMJ study revealed a… Continue reading Build a High-Value Depo-Provera Docket with Verified, Audit-Ready Retainers
Compliance Shield Depo-Provera litgation
Depo-Provera MDL – How We Filter for the “5.6x Risk” Cohort
March 14, 2026 by Mohr Marketing Depo-Provera MDL Science-Back Intake: How We Filter for the “5.6x Risk” Cohort The catalyst for the Depo-Provera MDL was a bombshell study published in the British Medical Journal (BMJ) in March 2024. That study didn’t just suggest a link; it identified a specific 5.6-fold increased risk of developing meningiomas for women using the drug for… Continue reading Depo-Provera MDL – How We Filter for the “5.6x Risk” Cohort
Compliance Shield Depo-Provera Liability Litigation
Why Depo-Provera is the Strategic Play for 2025-2026
March 13, 2026 by Mohr Marketing The $3B Liquidity Advantage: Why Depo-Provera is the Strategic Play for 2025-2026 As many mass torts face defendants with thinning capital, the Depo-Provera litigation stands out for its defendant solvency. Pfizer holds massive liquidity, providing the “muscle” to absorb a global settlement without the existential risks seen in other recent litigations. A Mature Docket with… Continue reading Why Depo-Provera is the Strategic Play for 2025-2026
Compliance Shield Depo-Provera Liability Litigation
Recent Posts
Categories
Archives

Copyright © 1994-2025 Mohr Marketing, LLC. All Rights Reserved.